These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20160709)

  • 1. Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.
    Althaus CL; De Boer RJ
    Mol Syst Biol; 2010; 6():348. PubMed ID: 20160709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
    Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection.
    Azoz SA; Coombs D
    Bull Math Biol; 2019 Jan; 81(1):131-154. PubMed ID: 30298198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the effect of tat inhibitors on HIV latency.
    Aguilera LU; Rodríguez-González J
    J Theor Biol; 2019 Jul; 473():20-27. PubMed ID: 31004612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV.
    Tabarrini O; Desantis J; Massari S
    Future Med Chem; 2016; 8(4):421-42. PubMed ID: 26933891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.
    Wang S; Rong L
    J Theor Biol; 2014 Nov; 360():137-148. PubMed ID: 25016044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong
    Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and latent reservoir persistence in HIV-1-infected patients on therapy.
    Kim H; Perelson AS
    PLoS Comput Biol; 2006 Oct; 2(10):e135. PubMed ID: 17040122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
    Rong L; Perelson AS
    PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy.
    Sánchez-Taltavull D; Vieiro A; Alarcón T
    J Math Biol; 2016 Oct; 73(4):919-46. PubMed ID: 26921201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
    McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillatory viral dynamics in a delayed HIV pathogenesis model.
    Wang Y; Zhou Y; Wu J; Heffernan J
    Math Biosci; 2009 Jun; 219(2):104-12. PubMed ID: 19327371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of an HIV Model with Multiple Infection Stages and Treatment with Different Drug Classes.
    Wang X; Song X; Tang S; Rong L
    Bull Math Biol; 2016 Feb; 78(2):322-49. PubMed ID: 26842389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.